SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (49476)12/18/2003 1:42:44 PM
From: Libbyt  Read Replies (1) of 57110
 
GERN...

Do you have any thoughts about the "rumor" of GERN being purchased by Roche? It was reported yesterday as a rumor that Roche would pay $24-27 a share for GERN.

It seems to make "sense" since Roche is based in Switzerland, and sells its products to 150 countries. The "stem cell" controversial issues would seem to be a "non-issue" if Geron was part of Roche.

Congratulations....I saw the post where you won the Biotech Stock Picking Contest for 2003! What a fantastic record of biotech stocks you picked!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext